The identification of NCOR2 as one of the top eight genes responding to combination therapy in ovarian cancer is significant because like BDP1, NCOR2 contains a SANT domain (SWI3, ADA2, N‐Cor, and yeast TFIIIB BDP1 proteins) (reviewed in17). Here, NCOR2 is linked to ovarian carcinoma.